These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31744879)
1. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis. Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879 [TBL] [Abstract][Full Text] [Related]
2. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids. Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970 [TBL] [Abstract][Full Text] [Related]
3. Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis. Laski J; Singha B; Wang X; Valdés YR; Collins O; Shepherd TG J Ovarian Res; 2020 May; 13(1):58. PubMed ID: 32393385 [TBL] [Abstract][Full Text] [Related]
4. LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway. Takahashi Y; Serada S; Ohkawara T; Fujimoto M; Hiramatsu K; Ueda Y; Kimura T; Takemori H; Naka T Biochem Biophys Res Commun; 2021 Jan; 537():93-99. PubMed ID: 33388415 [TBL] [Abstract][Full Text] [Related]
5. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783 [TBL] [Abstract][Full Text] [Related]
6. A novel role for NUAK1 in promoting ovarian cancer metastasis through regulation of fibronectin production in spheroids. Fritz JL; Collins O; Saxena P; Buensuceso A; Ramos Valdes Y; Francis KE; Brown KR; Larsen B; Colwill K; Gingras AC; Rottapel R; Shepherd TG Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429240 [TBL] [Abstract][Full Text] [Related]
7. Metabolic adaptation in epithelial ovarian cancer metastasis. Frederick MI; Nassef MZ; Borrelli MJ; Kuang S; Buensuceso A; More T; Cordes T; O'Donoghue P; Shepherd TG; Hiller K; Heinemann IU Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167312. PubMed ID: 38901649 [TBL] [Abstract][Full Text] [Related]
8. Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer. Buensuceso A; Fritz JL; Collins O; Valdés YR; Borrelli MJ; DiMattia GE; Shepherd TG Sci Rep; 2022 Feb; 12(1):3011. PubMed ID: 35194062 [TBL] [Abstract][Full Text] [Related]
9. Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis. Frederick MI; Hovey OFJ; Kakadia JH; Shepherd TG; Li SSC; Heinemann IU Mol Cell Proteomics; 2023 Nov; 22(11):100660. PubMed ID: 37820923 [TBL] [Abstract][Full Text] [Related]
10. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids. Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799 [TBL] [Abstract][Full Text] [Related]
11. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation. McKenzie AJ; Hicks SR; Svec KV; Naughton H; Edmunds ZL; Howe AK Sci Rep; 2018 May; 8(1):7228. PubMed ID: 29740072 [TBL] [Abstract][Full Text] [Related]
12. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384 [TBL] [Abstract][Full Text] [Related]
13. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer. Xu JH; Wang Y; Xu D Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074 [TBL] [Abstract][Full Text] [Related]
14. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027 [TBL] [Abstract][Full Text] [Related]
15. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids. He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439 [TBL] [Abstract][Full Text] [Related]
16. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289 [TBL] [Abstract][Full Text] [Related]
17. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1. Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838 [TBL] [Abstract][Full Text] [Related]
19. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer. Peng J; Yang X; Li X; Gao H; Liu N; Guo X Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719 [TBL] [Abstract][Full Text] [Related]
20. An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential. Goodwin JM; Svensson RU; Lou HJ; Winslow MM; Turk BE; Shaw RJ Mol Cell; 2014 Aug; 55(3):436-50. PubMed ID: 25042806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]